Private Equity

Pike Street Capital

Investment Details

Investor Type
Private Equity

Asset Class Focus
Private Equity

Stage Focus
Buyout, Growth

Geographical Focus
United States, Canada

Industries Focus

  • Business Services
  • Industrial Technology
  • Distribution & Logistics
  • Specialty Manufacturing

Investment Size:
10,000,000 to 50,000,000 USD

Investor Details Founded: 2017

Pike Street Capital is a Seattle-based private equity firm specializing in growth buyouts within the industrial technology sector. With over 75 years of combined investing and operating experience, the firm partners with management teams to build and execute strategies for future growth. Pike Street Capital focuses on lower middle-market companies, targeting those with EBITDA between $4 million and $15 million. The firm seeks investments where its operational focus, business experience, and executive network can assist management in accelerating growth. The firm's investment criteria include equity investments between $10 million and $50 million per transaction, with target transaction sizes ranging from $20 million to $120 million. Pike Street Capital's portfolio includes investments in companies such as US BioTek Laboratories, Head Rush Technologies, and Radiant Vision Systems. The firm is led by co-founders Paul Caragher, Dave Dandel, and Ed Whatley, who bring complementary backgrounds in entrepreneurship, operations, and transactions to the firm. Pike Street Capital's approach emphasizes partnering with founders, owners, and management teams to implement successful growth strategies, develop strong teams, and create a culture of performance. The firm leverages its integrated investment and operational approach to drive long-term value creation, working closely with management teams to accelerate growth, enhance capabilities, scale operations, and build market-leading businesses. Pike Street Capital's investment philosophy centers on identifying companies with strong technical expertise, established market positions, strong management teams, and discernible growth drivers. The firm targets sectors serving professional and technical customers and commercial growth where it has relevant investing and operating experience, including industrial technology, specialty manufacturing, distribution & logistics, and business services. The firm's portfolio companies benefit from Pike Street Capital's operational focus, business experience, and executive network, which assist management in accelerating growth and achieving the next level of success. Pike Street Capital's commitment to partnering with management teams and providing strategic guidance has led to successful investments and a strong track record in the private equity industry. The firm's focus on the industrial technology sector allows it to leverage its expertise and network to drive value creation and support the growth of its portfolio companies. Pike Street Capital's approach to private equity emphasizes collaboration with management teams to implement growth strategies, develop strong teams, and create a culture of performance, leading to successful outcomes for its portfolio companies and investors.

Requirements
  • EBITDA between $4 million and $15 million
  • Equity investments between $10 million and $50 million per transaction
  • Target transaction sizes ranging from $20 million to $120 million
  • Focus on lower middle-market companies in the industrial technology sector
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • US BioTek Laboratories
  • Head Rush Technologies
  • Radiant Vision Systems
Claim this Investor

Are you an official representative of Pike Street Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim